The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study

Table 1 Participant characteristics by viral load status, North West Province, South Africa, 2014^a

	Not Suppressed (≥ 5000 copies/ml) wgt n = 7981		Suppressed (< 5000 copies/ml) wgt n = 4976
	wgt %	95% CI	wgt %	95% CI	P-value
Overall	61.6	(51.4–70.9)	38.4	(29.2–48.6)
Sex
Male	51.1	(41.0–61.1)	21.1	(10.4–38.2)	0.003
Female	48.9	(38.9–59.1)	78.9	(61.8–89.6)
Age group
18–29 Years	22.2	(11.4–38.7)	19.0	(9.2–35.1)	0.868
30–39 Years	45.0	(31.0–59.9)	42.7	(28.1–58.7)
40–49 Years	32.8	(22.1–45.6)	38.3	(24.5–54.4)
Education
Primary or Less	30.2	(20.3–42.4)	35.3	(21.6–52.0)	0.759
Some Secondary	39.3	(30.0–49.5)	39.8	(28.0–53.0)
Completed Secondary	30.5	(22.2–40.2)	24.8	(13.2–41.8)
Prior knowledge of HIV serostatus^b
Known Positive	54.2	(41.7–66.1)	86.0	(68.6–94.6)	0.005
Unknown	45.8	(33.9–58.3)	14.0	(5.4–31.4)^e
ART initiation^b
No	19.7	(10.4–34.3)	4.8	(1.4–15.1)	0.040
Yes	80.3	(65.7–89.6)	95.3	(85.0–98.6)
Time on ART^b
< 1 year	23.4	(14.4–35.9)	13.8	(7.4–24.3)	0.134
1–3 years	42.9	(29.4–57.5)	33.7	(18.7–52.8)
> 3 years	33.7	(21.9–48.0)	52.5	(30.8–58.5)
Analytes found^c
Yes	33.3	(25.3–42.4)	75.5	(57.9–87.4)	< 0.001
No	66.7	(57.6–74.7)	24.5	(12.6–42.2)
CD4 category (Pima)^d
≤ 350 cells/μL	57.8	(42.8–71.5)	28.2	(15.7–45.2)	0.018
> 350 cells/μL	42.2	(28.6–57.2)	71.9	(54.8–84.3)

^aWeights account for sampling, non-response, and age/sex of target population
^bBased on self-report
^cAssessed for EFV, LPV, NVP
^dAmong those for whom Pima CD4 results were available
^eRespondents may be mis-reporting status, be elite controllers, or on ART without understanding of their condition [35]

ISSN: 1471-2334